1. Home
  2. RXRX vs ENOV Comparison

RXRX vs ENOV Comparison

Compare RXRX & ENOV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Recursion Pharmaceuticals Inc.

RXRX

Recursion Pharmaceuticals Inc.

HOLD

Current Price

$3.82

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Logo Enovis Corporation

ENOV

Enovis Corporation

HOLD

Current Price

$18.54

Market Cap

1.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
RXRX
ENOV
Founded
2013
1995
Country
United States
United States
Employees
N/A
7802
Industry
Biotechnology: Pharmaceutical Preparations
Fluid Controls
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.7B
1.0B
IPO Year
2021
2008

Fundamental Metrics

Financial Performance
Metric
RXRX
ENOV
Price
$3.82
$18.54
Analyst Decision
Buy
Strong Buy
Analyst Count
4
9
Target Price
$7.50
★ $47.38
AVG Volume (30 Days)
★ 17.2M
1.9M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
★ 14.79
N/A
EPS
N/A
★ N/A
Revenue
★ $74,681,000.00
N/A
Revenue This Year
$12.11
$6.36
Revenue Next Year
$82.52
$5.31
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 26.92
N/A
52 Week Low
$2.77
$17.30
52 Week High
$7.18
$34.28

Technical Indicators

Market Signals
Indicator
RXRX
ENOV
Relative Strength Index (RSI) 57.52 37.86
Support Level $2.90 $17.30
Resistance Level $4.05 $27.20
Average True Range (ATR) 0.24 0.94
MACD 0.03 0.23
Stochastic Oscillator 69.16 45.19

Price Performance

Historical Comparison
RXRX
ENOV

About RXRX Recursion Pharmaceuticals Inc.

Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. The company is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery. Geographically, the company operates in United States, United Kingdom, and Others. It derives maximum revenue from United States.

About ENOV Enovis Corporation

Enovis Corp is a medical technology manufacturer and distributor of medical devices used in reconstructive surgery, rehabilitation, pain management, and physical therapy. Its products support patient care from injury prevention through post-surgical or post-injury rehabilitation and treatment of degenerative conditions. The company's reportable segments include Prevention & Recovery and Reconstructive segments. The majority of revenueis derived from the Prevention & Recovery segment, which includes products that are used by orthopedic specialists, primary care physicians, physical therapists, chiropractors, athletic trainers and other healthcare professionals to treat patients with musculoskeletal conditions resulting from degenerative diseases, deformitiesand sports-related injuries.

Share on Social Networks: